Journal: Journal of Virology
Article Title: PEX19 restricts porcine deltacoronavirus replication through farnesylation-dependent and -independent mechanisms
doi: 10.1128/jvi.02097-25
Figure Lengend Snippet: PEX19 exhibits stronger anti-PDCoV activity. ( A and B ) LLC-PK1 cells were transfected with plasmids encoding PEX5, PEX7, PEX11α, PEX11β, PEX11γ, PEX12, PEX14, PEX16, PEX19, or an empty vector as control. At 12 h post-transfection, cells were infected with PDCoV at a multiplicity of infection (MOI) of 1. At 12 h post-infection, cell lysates and supernatants were harvested to assess viral replication by RT-qPCR ( A ) and TCID₅₀ assay ( B ). ( C and D ) Dose-dependent inhibition of PDCoV replication by PEX19. LLC-PK1 cells were transfected with increasing amounts (0, 0.5, 1.0, and 2.0 μg) of PEX19 expression plasmid. At 12 h post-transfection, cells were infected with PDCoV (MOI=1). Samples were harvested at 12 h post-infection for viral RNA quantification by RT-qPCR ( C ) and viral titration by TCID 50 assay ( D ). ( E and F ) Generation and validation of PEX19 knockout (KO) cells. PEX19 expression was analyzed by immunofluorescence assay (scale bar, 5 μm). ( E ) and Western blotting ( F ) using a rabbit polyclonal antibody against PEX19. ( G and H ) Effects of PEX19 knockout and complementation on PDCoV replication. PEX19 KO cells were transfected with either the PEX19 expression plasmid or the empty vector. WT LLC-PK1 cells, which were transfected with an empty vector, were used as controls. At 12 h post-transfection, cells were infected with PDCoV (MOI = 1), and samples were collected 12 h later for RT-qPCR ( G ) and TCID 50 assay ( H ). Values are shown as means ± SD. Statistical analyses for panels A to D, G, and H were performed with one-way ANOVA. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
Article Snippet: LLC porcine kidney (LLC-PK1) cells were purchased from the American Type Culture Collection (ATCC CL-101; Manassas, VA, USA).
Techniques: Activity Assay, Transfection, Plasmid Preparation, Control, Infection, Quantitative RT-PCR, Inhibition, Expressing, Titration, Biomarker Discovery, Knock-Out, Immunofluorescence, Western Blot